drugset / Trial / NCT00090298

Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)

NCT00090298

Phase 3 Completed 2815 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

A 10-week study to compare the reduction in cholesterol following treatment with two different marketed drugs in patients with hypercholesterolemia.

Timeline

Start
2004-04
Primary completion
2004-12
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown
Subject Rosuvastatin Small molecule
Subject Simvastatin Small molecule

Indications